Showing 871-880 of 1374 results for "".
- Skin Moderne Debuts Plant-Derived Exosomes Regenerative Complex for Advanced Skin Renewalhttps://modernaesthetics.com/news/skin-moderne-debuts-plant-derived-exosomes-regenerative-complex-for-advanced-skin-renewal/2475496/Skin Moderne announced the launch of Exosomes Regenerative Complex, a plant-based formulation designed to deliver deep skin rejuvenation without irritation, injury, or downtime, according to a news release.
- Atlanta-Based Hair Transplant Specialist Now Accepting Bitcoin as Paymenthttps://modernaesthetics.com/news/atlanta-based-hair-transplant-specialist-now-accepting-bitcoin-as-payment/2475386/Kalos Hair Transplant, a hair restoration practice led by facial plastic surgeon Dr. Benjamin Stong, is now accepting Bitcoin (BTC) as payment for its medical procedures. The Atlanta-based clinic is among the first dedicated hair transplant practices in the United States to formally integrate cry
- Midmark Announces First USAB Compliant Procedure Chairhttps://modernaesthetics.com/news/midmark-announces-first-usab-compliant-procedure-chair/2475384/Midmark Corp. announced the launch of the Midmark 631 procedure chair, which the company said is the first US Access Board (USAB) compliant procedure chair. In 2024, the U.S. Access Board issued a new standard establishing design criteria for examinati
- SkinSpirit Shows Pride Month Support with $10,000 Donation to The Trevor Projecthttps://modernaesthetics.com/news/skinspirit-shows-pride-month-support-with-10000-donation-to-the-trevor-project/2475383/June kicked off Pride month in the United States and national medspa chain SkinSpirit is showing support through its philanthropic arm, SS Gives. SkinSpirit is donating $10,000 to The Trevor Project. “At SkinSpirit, one of our core values is leading with love,” Ly
- 2025 SCALE: Enhancing Injection Safety and Precision with Ultrasound Guidancehttps://modernaesthetics.com/news/2025-scale-enhancing-injection-safety-and-precision-with-ultrasound-guidance/2475379/At the 20th anniversary of Music City Symposium for Cosmetic Advances and Laser Education (SCALE), Benjamin Ascher, MD, gave a lecture titled “Why Injections Under Ultrasound Guide Are Crucial in Aesthetic Medicine.” Dr. Ascher explained shifts in facial injection practices,
- Dr. CI:Labo Presents New Clinical Data on Post-IPL Skincare for Asian Skin at IMCAS Asia 2025https://modernaesthetics.com/news/dr-cilabotm-presents-new-clinical-data-on-post-ipl-skincare-for-asian-skin-at-imcas-asia-2025/2475378/At IMCAS Asia 2025, Dr.CI:LABOTM presented new clinical findings demonstrating the efficacy of two of its skincare products—VC100 Essence Lotion EX and 377VC Radiance Serum—as adjuncts to Intense Pulsed Light (IPL) treatments in Asian patients. The data reve
- 2025 SCALE: Temple Filler Is Underappreciated But Crucialhttps://modernaesthetics.com/news/2025-scale-temple-filler-is-underappreciated-but-crucial/2475375/At the 20th anniversary of the Music City Symposium for Cosmetic Advances and Laser Education (SCALE), Vince Bertucci, MD, FRCPC, gave a lecture titled “Temple Fillers: Revisiting Current Dogma.” Key takeaway messages from the lecture included: <
- Cartessa Aesthetics Brings Aesthetic Devices to Canadahttps://modernaesthetics.com/news/cartessa-aesthetics-brings-aesthetic-devices-to-canada/2475372/Cartessa Aesthetics is expanding its Canadian portfolio with the launch of four new technologies, HELIX, TORO, EVERESSE, and ULTRAFORMER MPT, according to a press release from the manufacturer
- Revance Announces CEO Transitionhttps://modernaesthetics.com/news/revance-announces-ceo-transition/2475370/Revance announced a leadership transition last week as part of a long-term succession strategy following its integration with Crown Laboratories, according to a news release from the company.
- First Patient Dosed with GPX4 Modulator Targeting Pathologic Senescent Cellshttps://modernaesthetics.com/news/first-patient-dosed-with-gpx4-modulator-targeting-pathologic-senescent-cells/2475369/The first patient has been dosed with the lead drug candidate RLS-1496 in a single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial, Rubedo Life Sciences, Inc., announced in a press release. The study marks the first time a glu